###begin article-title 0
Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22
###end article-title 0
###begin p 1
###xml 33 55 33 55 <email xmlns:xlink="http://www.w3.org/1999/xlink">takatorih@mail.nih.gov</email>
CORRESPONDENCE Hiroaki Takatori: takatorih@mail.nih.gov
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 358 378 358 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Curr. Opin. Immunol.</italic>
###xml 425 434 425 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunity.</italic>
###xml 647 650 647 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 675 678 675 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 697 700 693 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 759 760 755 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 763 764 759 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 769 770 765 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 775 776 771 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 779 780 775 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 785 786 781 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 790 791 786 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 999 1004 <span type="species:ncbi:4932">yeast</span>
The interleukin (IL) 17 family of cytokines has emerged to be critical for host defense as well as the pathogenesis of autoimmune and autoinflammatory disorders, and serves to link adaptive and innate responses. Recent studies have identified a new subset of T cells that selectively produce IL-17 (Th17 cells; Bettelli, E., T. Korn, and V.K. Kuchroo. 2007. Curr. Opin. Immunol. 19:652-657; Kolls, J.K., and A. Linden. 2004. Immunity. 21:467-476), but the regulation of IL-17 production by innate immune cells is less well understood. We report that in vitro stimulation with IL-23 induced IL-17 production by recombination activating gene (Rag) 2-/- splenocytes but not Rag2-/- common gamma chain-/- splenocytes. We found that a major source of IL-17 was CD4+CD3-NK1.1-CD11b-Gr1-CD11c-B220- cells, a phenotype that corresponds to lymphoid tissue inducer-like cells (LTi-like cells), which constitutively expressed the IL-23 receptor, aryl hydrocarbon receptor, and CCR6. In vivo challenge with the yeast cell wall product zymosan rapidly induced IL-17 production in these cells. Genetic deletion of signal transducer and activator of transcription 3 reduced but did not abrogate IL-17 production in LTi-like cells. Thus, it appears that splenic LTi-like cells are a rapid source of IL-17 and IL-22, which might contribute to dynamic organization of secondary lymphoid organ structure or host defense.
###end p 3
###begin p 4
C.M. Tato's present address is Dept. of Discovery Research, DNAX Research Inc., Palo Alto, CA 94304.
###end p 4
###begin p 5
G. Weiss's present address is National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852.
###end p 5
###begin p 6
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 453 454 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 456 457 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 536 537 533 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 577 578 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 611 612 608 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 715 716 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 811 812 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 814 815 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 1001 1002 990 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1003 1005 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
Naive T cells undergo differentiation on signals received from the TCR and cytokine receptors and differentiate to specialized subsets characterized by their production of signature cytokines. Th17 cells produce IL-17 or IL-17A and IL-17F, which are major mediators of inflammation and are critical for host defense against extracellular bacteria and fungi (1, 2). IL-6, IL-21, and TGF-beta1 are critical factors that promote Th17 cell differentiation (1, 3). Although IL-23 was originally thought to be important for inducing naive CD4+ T cells to become Th17 cells, naive CD4+ T cells do not express IL-23Rs (4). Rather, IL-23 is now thought to affect the expansion, maintenance, and pathogenicity of Th17 cells (5). IL-23 also induces IL-17 production from gammadelta T cells and invariant NKT (iNKT) cells (6, 7). Regardless of exactly how IL-23 works, current evidence clearly argues that IL-23-mediated IL-17 production is crucial in host defense and in the pathogenesis of autoimmune diseases (8-10).
###end p 6
###begin p 7
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il17</italic>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il21</italic>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 425 427 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
###xml 134 137 <span type="species:ncbi:9606">man</span>
IL-6, IL-21, and IL-23 share the ability to activate Stat3, which was shown to be critical for Th17 cell differentiation in mouse and man (3, 11, 12). Stat3 directly regulates the Il17 and Il21 genes but also regulates IL-23R expression (3, 12). Furthermore, the aforementioned cytokines acting via Stat3 induce the retinoic acid-related orphan receptor gammat (RORgammat), the master regulator of Th17 cell differentiation (13).
###end p 7
###begin p 8
###xml 269 271 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 322 327 <span type="species:ncbi:4932">yeast</span>
In contrast to T cells, much less is known about the ability of innate cell subpopulations to produce IL-17. We report that splenic lymphoid tissue inducer-like cells (LTi-like cells) constitutively express RORgammat, IL-23R, CCR6, and aryl hydrocarbon receptor (AHR) (14), and produce IL-17 and IL-22. Interestingly, the yeast wall product zymosan elicited IL-17 production by LTi-like cells in vivo. Whether the production of IL-17 and IL-22 influences the architecture of secondary lymphoid organs (SLOs) and contributes to host defense will be important issues to examine in the future.
###end p 8
###begin title 9
RESULTS AND DISCUSSION
###end title 9
###begin title 10
IL-23 induces IL-17 production by a population of common gamma chain (gammac)-dependent non-T, non-B cells
###end title 10
###begin p 11
###xml 110 113 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 207 210 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 277 285 277 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 462 465 462 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 511 514 511 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 528 536 528 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 552 555 552 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 633 641 633 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 812 815 812 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 881 882 881 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 942 943 942 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 980 983 980 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1126 1129 1118 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 984 988 <span type="species:ncbi:10090">mice</span>
To determine if there are considerable proportions of innate immune cells that produce IL-17, we examined Rag2-/- mice that have few T and B cells. We first assessed whether IL-17 production occurred in Rag2-/- splenocytes after stimulation with various cytokines. As shown in Fig. 1 A, IL-23 alone induced IL-17A production by WT splenocytes, presumably indicative of an effect on memory T cells. Consistent with the idea that memory T cells are lacking in Rag2-/- mice, the effect of IL-23 was reduced in Rag2-/- splenocytes (Fig. 1 A). However, Rag2-/- splenocytes still produced about one third as much IL-17A as WT splenocytes (Fig. 1 A). Other cytokines used separately or in combination with IL-23 had no effect on IL-17A production; however, IL-4 suppressed IL-23-induced IL-17A production by WT and Rag2-/- splenocytes (Fig. S1 A, available at ). In addition to memory CD4+ T cells, iNKT cells are another important source of IL-17 (7), but such cells are lacking in Rag2-/- mice. Accordingly, anti-CD3/28 or alpha-galactosylceramide (alpha-GalCer) stimulation induced IL-17A production by WT splenocytes but not Rag2-/- splenocytes (Fig. S1, B and C). Collectively, these data suggest that although T and NKT cells are both major producers of IL-17, populations of non-T, non-B cells can also produce IL-17.
###end p 11
###begin p 12
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IL-23 and zymosan induce IL-17 production in a population of non&#8211;B, non&#8211;T cells.</bold>
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 342 343 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 376 379 374 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 388 391 386 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 397 400 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 624 625 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 708 711 700 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
###xml 1048 1052 <span type="species:ncbi:10090">mice</span>
IL-23 and zymosan induce IL-17 production in a population of non-B, non-T cells. (A) WT or Rag2-/- splenocytes were cultured in the presence of the indicated cytokines for 48 h, and IL-17A in culture supernatants was measured by ELISA. The data are means +/- SD from duplicate cultures and are representative of four independent experiments (n = 8). **, P < 0.01. (B) WT, Rag2-/-, or Rag2-/-gammac-/- splenocytes were cultured in the presence of IL-23 alone, and IL-17A in culture supernatants was measured by ELISA. The data are means +/- SD from duplicate cultures and are representative of three independent experiments (n = 6). *, P < 0.05; **, P < 0.01. (C) Sera and splenocytes were harvested from Rag2-/- mice after injection of 5 mg zymosan or PBS (Control). (left) IL-17A in sera was measured by ELISA. (right) The relative expression levels (/18S) of IL-17A mRNA were analyzed by quantitative PCR (q-PCR) and are depicted as fold induction relative to cells 1 h after treatment with zymosan. The data are means +/- SD of results from two mice per group per time point and are representative of two independent experiments. ND, not detected.
###end p 12
###begin p 13
###xml 103 106 103 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 166 169 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 175 178 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 227 230 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 236 239 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 295 298 287 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 307 310 299 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 316 319 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 374 382 362 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 466 469 454 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 483 491 471 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 532 535 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 541 544 525 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 584 592 568 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
To identify which population of cells might be responsible for IL-23-dependent IL-17 production by Rag2-/- splenocytes, we examined another genetic model, namely Rag2-/-gammac-/- mice. In addition to lacking T and B cells, Rag2-/-gammac-/- mice also lack NK cells. We therefore cultured WT, Rag2-/-, or Rag2-/-gammac-/- splenocytes in the presence of IL-23. Consistent with Fig. 1 A, IL-17A production was present in WT splenocytes and reduced but not absent in Rag2-/- splenocytes (Fig. 1 B). In contrast, IL-17A production by Rag2-/-gammac-/- splenocytes was essentially abrogated (Fig. 1 B). These results indicate that gammac-dependent, non-T, non-B cell populations in the spleen can produce IL-17 in vitro.
###end p 13
###begin p 14
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 75 78 75 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 219 227 219 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
IL-23 has been shown to be induced by certain microbial products (15). Rag2-/- mice were therefore injected with zymosan to induce IL-23 production by DCs, which resulted in rapid IL-17A appearance in sera and spleens (Fig. 1 C). Thus, these data indicate that innate immune cells can generate IL-17 in response to the fungal product in vivo.
###end p 14
###begin title 15
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
IL-17 production by CD4+CD3-CD11c-B220- LTi-like cells
###end title 15
###begin p 16
###xml 183 186 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 452 455 448 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 484 487 480 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 493 496 485 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 636 637 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 667 675 659 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 852 855 836 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 892 895 876 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 931 939 915 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 1025 1033 1009 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
To delineate the population of IL-17-producing cells, we next used intracellular cytokine staining. We used markers for a variety of innate immune cells expected to be present in Rag2-/- spleens but failed to detect IL-23-mediated IL-17A production in granulocytes, macrophages, or DCs (Fig. S2, available at ). A prominent gammac-dependent lineage that rapidly produces cytokines upon stimulation is the NK cell. Based on the response to IL-23 in Rag2-/- splenocytes and loss in Rag2-/-gammac-/- splenocytes, we thought that NK cells could be IL-17 producers. However, contrary to our expectations, the majority of IL-17A-producing CD3- cells did not express NK1.1 (Fig. 2 A). Thus far, our results have indicated that neither T, NKT, NK cells (all gammac dependent) nor gammac-independent myeloid cells were a major source of IL-17 production in Rag2-/- spleens. We did observe that in Rag2-/- splenocytes stimulated with IL-23 (Fig. 2 B, left), a considerable proportion of the IL-17A-producing non-T cells expressed CD4 (Fig. 2 B, right).
###end p 16
###begin p 17
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD4<sup>+</sup>CD3<sup>&#8722;</sup>lineage<sup>&#8722;</sup> cells produce IL-17.</bold>
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 224 225 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 239 240 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 259 260 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 288 289 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 335 336 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 367 368 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
CD4+CD3-lineage- cells produce IL-17. Rag2-/- splenocytes were cultured in the absence (Control) or presence of IL-23 for 24 h. The proportion of IL-17A-producing CD3- cells was evaluated by intracellular staining. (A) NK1.1+ versus IL-17A+ cells gated on CD3- cells are shown. (B) IL-17A+ versus CD3+ cells (nongated; left) and IL-17A+ versus CD4+ cells gated on CD3- cells (right) are shown. Data are representative of three independent experiments.
###end p 17
###begin p 18
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 144 145 144 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 148 149 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 310 311 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 314 315 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 320 321 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 325 326 325 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 513 516 509 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 523 525 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
CD4+CD3- cells in the Rag2-/- spleen comprise three populations, including CD11ClowB220+ plasmacytoid DCs, CD11C+B220- conventional DCs, and CD4+CD3-CD11c-B220- cells (Fig. S3, available at ). As indicated in Fig. S2, we did not detect IL-23-mediated IL-17A production by CD11C+ DC populations. The latter, CD4+CD3-CD11c-B220- cells, have been shown to be present in SLOs of fetal and adult mice and are termed LTi's and LTi-like cells, respectively (16). Importantly, LTi-like cells are greatly reduced in gammac-/- mice (17).
###end p 18
###begin p 19
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 89 97 89 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 126 134 126 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 371 379 371 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 513 514 513 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 632 637 <span type="species:ncbi:10090">mouse</span>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
We next determined whether isolated CD4+CD3-CD11c-B220- LTi-like subsets produced IL-17 (Fig. 3 A, top). In fact, as shown in Fig. 3 A (bottom), we observed IL-17A production by isolated LTi-like cells in response to IL-23. Moreover, directly isolated LTi-like cells produced more IL-17A in the presence of PMA/ionomycin (Iono), which was dramatically enhanced by IL-23 (Fig. 3 A, bottom). In contrast, LTi-negative subsets produced minimal IL-17A (Fig. S4, available at ). Consistent with Fig. S2, isolated CD11c+ cells did not produce IL-17A with IL-23 stimulation (unpublished data). Another source of LTi-like cells in an adult mouse is the intestinal lamina propria (16). Interestingly, LTi-like cells in the lamina propria from WT mice produced IL-17A after stimulation with PMA/Iono (Fig. S5). These results suggest that the ability to produce IL-17 is not unique to the splenic population.
###end p 19
###begin p 20
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 0 118 0 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Isolated CD4<sup>+</sup>CD3<sup>&#8722;</sup>CD11c<sup>&#8722;</sup>B220<sup>&#8722;</sup> LTi-like cells produce IL-17 and constitutively express IL-23R, ROR&#947;t, AHR, and CCR6.</bold>
###xml 135 136 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 139 140 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 145 146 141 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 150 151 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 178 181 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 466 471 460 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fl/fl</sup>
###xml 461 471 455 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat3<sup>fl/fl</sup></italic>
###xml 480 485 474 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fl/fl</sup>
###xml 475 495 469 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat3<sup>fl/fl</sup>; MMTV-Cre</italic>
###xml 771 772 763 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 857 860 849 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 487 491 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Isolated CD4+CD3-CD11c-B220- LTi-like cells produce IL-17 and constitutively express IL-23R, RORgammat, AHR, and CCR6. (A) Isolated CD4+CD3-CD11c-B220- LTi-like subsets from Rag2-/- splenocytes (top) were cultured in the absence (Control) or presence of IL-23 (or with PMA/Iono) for 24 h, and IL-17A in culture supernatants was measured by ELISA (bottom). Data are means +/- SD from duplicate cultures and are representative of two independent experiments. (B) Stat3fl/fl or Stat3fl/fl; MMTV-Cre splenocytes were cultured in the absence (Control) or presence of IL-23 for 24 h. The proportion of IL-17A-producing LTi-like cells was evaluated by intracellular staining. Data are means +/- SD from duplicate cultures and are representative of four independent experiments (n = 8). *, P < 0.05. (C) Total RNA was prepared from LTi-like cells isolated from Rag2-/- spleens. The relative expression levels (/18S) of the indicated mRNA was analyzed by q-PCR and are depicted as fold induction relative to fresh B cells (or fresh naive T cells for AHR mRNA expression). Data are representative of three independent experiments. M-T, memory T cells; N-T, naive T cells. (D) The expression of CCR6 on LTi-like cells of WT splenocytes was analyzed by FACS. The shaded histogram indicates staining with isotype-matched control antibodies. The continuous line histogram indicates the surface expression level of CCR6 on LTi-like cells. Data are representative of three independent experiments. ND, not detected.
###end p 20
###begin p 21
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
One possible explanation for our observations is that IL-23 promoted in vitro survival of LTi-like cells rather than enhancing IL-17 production by itself. LTi-like cells have been shown to express IL-7Rs (Fig. S6, available at ) (16). Therefore, we modified the cell-culture conditions by adding IL-7 to maintain cells for the initial 48 h, followed by IL-23 for another 6 h. As shown in Fig. S7 A, IL-17A and IL-17F mRNA expression was potently induced by IL-23 in the presence of IL-7. These results suggest that LTi-like cells quickly enhance the production of IL-17 in response to IL-23, and this cytokine does not simply serve to keep these cells alive.
###end p 21
###begin p 22
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 386 391 386 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fl/fl</sup>
###xml 381 401 381 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat3<sup>fl/fl</sup>; MMTV-Cre</italic>
###xml 410 415 410 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fl/fl</sup>
###xml 405 424 405 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat3<sup>fl/fl</sup>; CD4-Cre</italic>
###xml 465 470 465 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fl/fl</sup>
###xml 460 470 460 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat3<sup>fl/fl</sup></italic>
###xml 541 549 541 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
It is well known that Stat3 is activated by IL-23 and other inducers of Th17 cell differentiation, and the absence of Stat3 abrogates IL-17 production by T cells (12). We therefore assessed the proportion of IL-17A-producing LTi-like cells in Stat3-deficient mice. Not surprisingly, we found that IL-23-mediated IL-17A production was decreased in Stat3-deficient LTi-like cells of Stat3fl/fl; MMTV-Cre or Stat3fl/fl; CD4-Cre splenocytes compared with those of Stat3fl/fl splenocytes, although IL-17A production was not completely abrogated (Fig. 3 B and not depicted). Because Cre-mediated deletion of STAT3 is >90% in both systems (unpublished data), there seems to be both STAT3-dependent and -independent pathways for the production of IL-17 in LTi-like cells. We also observed that IL-23 up-regulated mRNA expression of Stat3 and Stat4 but not GATA3 in LTi-like cells (Fig. S7 B). These results highlight the notion that the IL-17 production by LTi-like cells might be dependent on these factors.
###end p 22
###begin title 23
LTi-like cells constitutively express IL-23R, AHR, and CCR6
###end title 23
###begin p 24
###xml 174 175 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 191 192 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 271 272 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 500 508 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 617 618 608 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 628 636 619 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 750 751 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 761 769 749 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 811 813 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 815 817 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 913 921 897 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 1135 1137 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 1258 1266 1238 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
The complete receptor for IL-23 comprises the IL-12Rbeta1 associated with the ligand-specific subunit IL-23R, and both subunits are required for the action of this cytokine (4). As memory CD4+ T cells respond to IL-23 because of constitutive expression of its receptors (4), we evaluated mRNA expression of IL-23R and IL-12Rbeta1 in LTi-like cells. Consistent with their rapid responsiveness to IL-23, LTi-like cells constitutively expressed IL-23R mRNA at levels significantly greater than T cells (Fig. 3 C). LTi-like cells also expressed slightly higher levels of IL-12Rbeta1 mRNA compared with those of memory CD4+ T cells (Fig. 3 C). In contrast, expression levels of IL-12Rbeta2 mRNA in LTi-like cells were low compared with those in memory CD4+ T cells (Fig. 3 C). Also consistent with previous studies (16, 18), we noted higher expression levels of RORgammat mRNA in LTi-like cells compared with T cells (Fig. 3 C). In contrast, expression of IL-6Ralpha and IL-17RA mRNA in LTi-like cells was much lower compared with that in T and B cells (unpublished data). Recently, the AHR has been reported to be expressed in Th17 cells (14). Interestingly, LTi-like cells also expressed AHR mRNA at levels equivalent to those in Th17 cells polarized for 72 h (Fig. 3 C). Furthermore, IL-23 up-regulated mRNA expression levels of IL-23R, RORgammat, and AHR (Fig. S7 C).
###end p 24
###begin p 25
###xml 34 36 34 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 38 40 38 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 101 102 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 112 113 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 119 123 111 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 127 131 119 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 136 139 128 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 221 222 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 231 232 223 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 234 236 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 238 240 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 421 422 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 463 465 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 531 539 523 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 572 573 564 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 756 758 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 876 878 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 405 410 <span type="species:ncbi:9606">human</span>
Consistent with previous studies (16, 18), splenic LTi-like cells were found to be CD30L+OX40L+gammac+IL-7Ralpha+Thy1.2highCD44highCD62Llow (Fig. S6). LTi-like cells are also known to express the chemokine receptors CXCR5+ and CCR7+ (16, 18), and we again confirmed expression of these in the splenic LTi-like cells (Fig. S6). Additionally, it has recently been shown that CCR6 identifies a population of human memory CD4+ T cells that selectively produce IL-17 (19), we found that most of the splenic LTi-like cells express CCR6 (Fig. 3 D). Approximately half of the CCR6+ LTi-like cells coexpressed CXCR5 and CCR7 (unpublished data), suggesting that the expression of those chemokine receptors on LTi-like cells is heterogeneous, as previously reported (20). On the other hand, the expression of CXCR3, CCR5, or CCR4, which are preferentially expressed on Th1 or Th2 cells (19), was low on splenic LTi-like cells (Fig. S6 and not depicted).
###end p 25
###begin title 26
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
LTi-like cells produce IL-17 during zymosan-induced inflammation in Rag2-/- mice
###end title 26
###begin p 27
###xml 156 159 156 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 417 423 417 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 649 652 649 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 872 878 872 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
We next determined whether LTi-like cells produced IL-17 in vivo in an inflammatory setting. We approached this problem in two ways: first, we injected Rag2-/- mice with zymosan i.p. to induce inflammation and harvested splenocytes 2 h later. The cells were then stimulated ex vivo with PMA/Iono and Brefeldin A (BFA) for 2 h, and the proportion of IL-17A-producing LTi-like cells was determined by FACS. As shown in Fig. 4 (top) the proportion of IL-17-producing LTi-like cells was significantly greater in zymosan-treated mice compared with control mice. To further establish the ability of LTi-like cells to produce IL-17 in vivo, we treated Rag2-/- mice with BFA i.v. (21) and challenged them with zymosan i.p. for 6 h. We observed few IL-17A-producing LTi-like cells in control mice, whereas zymosan-treated mice had a significant increase in IL-17A-producing cells (Fig. 4, bottom). These results establish that LTi-like cells can rapidly produce IL-17 in vivo when challenged with the product of fungal pathogens.
###end p 27
###begin p 28
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Zymosan induces IL-17 production in splenic LTi-like cells in vivo.</bold>
###xml 225 228 225 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 505 508 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 851 852 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 888 889 888 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
Zymosan induces IL-17 production in splenic LTi-like cells in vivo. (left) Intracellular staining of IL-17A was performed with in vitro conventional staining (top) or in vivo staining (bottom). For conventional staining, Rag2-/- mice were challenged with PBS (Control) or 12.5 mg zymosan i.p. Splenocytes were isolated 2 h later and stimulated with PMA/Iono and BFA for 2 h in vitro. The proportion of IL-17A-producing LTi-like cells was evaluated by intracellular staining. For the in vivo staining, Rag2-/- mice were injected with PBS (Control) or 12.5 mg zymosan i.p. together with 0.25 mg BFA i.v. (reference 22). The proportion of IL-17A-producing LTi-like cells in spleens was directly evaluated by intracellular staining. (right) The mean values (horizontal bars) for IL-17A-producing LTi-like cells were calculated for in vitro staining (top, n = 6) and in vivo staining (bottom, n = 6). Data are representative of three (top) or two (bottom) independent experiments. ***, P < 0.001.
###end p 28
###begin title 29
LTi-like cells also produce IL-22
###end title 29
###begin p 30
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 207 215 207 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 287 290 287 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 324 332 324 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 393 401 393 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 449 450 449 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 453 454 453 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 490 498 490 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
It has been argued that Th17 cells also preferentially produce IL-22 (22). Interestingly, we found that treatment with zymosan induced not only IL-17A but also IL-22 in the sera and spleens of Rag2-/- mice (Fig. 5 A). In vitro stimulation with IL-23 induced more IL-22 production by Rag2-/- splenocytes than WT splenocytes (Fig. 5 B). Furthermore, isolated LTi-like cells also produced IL-22 (Fig. 5 B and Fig. S7 D). Although we observed that NK1.1+CD3- NK cells failed to produce IL-17A (Fig. 2 A), isolated NK cells produced small amounts of IL-22 in response to IL-23 (Fig. S8, available at ). These findings illustrate the potentially distinct modes of regulation for IL-17 and IL-22.
###end p 30
###begin p 31
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">LTi-like cells produce high levels of IL-22.</bold>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 457 460 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
LTi-like cells produce high levels of IL-22. (A) Sera and splenocytes were harvested from Rag2-/- mice 3 h after injection of PBS (Control) or 5 mg zymosan. (left) IL-22 in sera was measured by ELISA. (right) The relative expression levels (/18S) of IL-22 mRNA were determined by q-PCR and are depicted as fold induction relative to control cells. The data are means +/- SD from two mice and are representative of two independent experiments. (B) WT or Rag2-/- splenocytes or isolated LTi-like cells were cultured in the presence of IL-23 for 24 h, and IL-22 in culture supernatants was measured by ELISA. The data are means +/- SD from duplicate cultures and are representative of two independent experiments.
###end p 31
###begin p 32
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 393 394 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 396 397 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 555 557 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
The IL-23-IL-17 axis has emerged to be important in host defense and in models of autoimmunity such as experimental autoimmune encephalomyelitis and inflammatory bowel disease (10, 23). Despite the importance of Th17 cells, it is becoming increasingly clear that they are not the only source of IL-17. Clearly, gammadelta T and iNKT cells produce IL-17 to protect against bacterial infection (6, 7). In addition, a recent study provides evidence that IL-23 can drive IL-17 production by innate immune cells in animal models of inflammatory bowel disease (23).
###end p 32
###begin p 33
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 71 74 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 81 89 77 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 234 235 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 238 239 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 250 258 246 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 341 343 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 463 465 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 467 469 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 601 603 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 681 689 661 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 953 961 933 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 1026 1041 1006 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, C and D</xref>
###xml 1059 1060 1039 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1066 1067 1046 1047 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1084 1085 1064 1065 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1131 1133 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 1135 1137 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 1068 1073 <span type="species:ncbi:9606">human</span>
We were very impressed by the loss of IL-17 production in Rag2-/-gammac-/- mice (Fig. 1 B). We initially suspected that this pointed to production of IL-17 by NK cells but were surprised by the failure to see IL-17 production by NK1.1+CD3- NK cells (Fig. 2 A). However, LTi-like cells are also dependent on gammac cytokines for development (17). Before our studies, it was known that these cells expressed RORgammat, which was required for their function in LNs (16, 18). RORgammat has several important functions, but it is now clear that one function is the regulation of Th17 cell differentiation (13). We confirmed that splenic LTi-like cells constitutively express RORgammat (Fig. 3 C) and that IL-23 further up-regulated its expression (Fig. S7 C), arguing that this factor is essential in controlling IL-17 and IL-22 production by non-T cells. Interestingly, fresh LTi-like cells also constitutively expressed more AHR than polarized Th17 cells (Fig. 3 C). LTi-like cells also constitutively expressed IL-23R and CCR6 (Fig. 3, C and D), similar to CCR6+IL-23R+ human memory CD4+ T cells, which are major producers of IL-17 (19, 24). Thus, the expression of RORgammat, AHR, CCR6, and IL-23R seems to be the signature to define IL-17- and IL-22-producing cells in both adaptive and innate immune cells.
###end p 33
###begin p 34
###xml 191 193 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 195 197 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 284 293 273 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Figs. 3 A</xref>
###xml 298 301 287 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">5 B</xref>
###xml 326 328 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 595 597 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 599 601 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 768 770 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 1024 1026 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 1066 1069 1055 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1115 1121 1104 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 1070 1074 <span type="species:ncbi:10090">mice</span>
LTi-like cells are involved in the proper formation of peripheral LNs, the spleen, and gut-associated lymphoid tissue by highly expressing lymphotoxin alpha, lymphotoxin beta, and TNF-alpha (16, 25). Our data indicate that splenic and gut LTi-like cells also produce IL-17 and IL-22 (Figs. 3 A and 5 B; and Fig. S7, A and D) (26). It has been recently shown that blocking IL-17 results in disruption of the germinal center-like formation in the spleen, and restoration of the lymphoid microanatomy is dependent on the proliferative accumulation of LTi-like cells in SLOs during viral infection (27, 28). In addition, the cross talk between bacteria, LTi cells, stromal cells, DCs, and B cells seems to be essential for isolated lymphoid follicle formation in the gut (29). LTi-like cells might help organize the development of lymphoid tissues through the production of IL-17. In addition, IL-17 and IL-22 act on epidermal cells, producing antimicrobial products that protect the host from extracellular bacteria and fungi (22). Our in vivo experiments in which Rag2-/- mice challenged with zymosan produced IL-17 (Fig. 4) are consistent with the notion that splenic LTi-like cells might participate in host defense. It is therefore possible that splenic LTi-like cells exist not only for the development of SLOs but also for the rapid response to pathogens that elicit IL-17 and IL-22. Thus, our report brings to light new potential roles of LTi-like cells in host defense in addition to their known roles in regulating lymphoid architecture.
###end p 34
###begin title 35
MATERIALS AND METHODS
###end title 35
###begin title 36
Recombinant cytokines and antibodies.
###end title 36
###begin p 37
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 80 85 <span type="species:ncbi:10090">Mouse</span>
Mouse IL-6, IL-12, IL-21, IL-23, and TGFbeta-1 were purchased from R&D Systems. Mouse IL-2, IL-4, IL-7, and IL-15 were purchased from PeproTech. Antibodies to CD4 (GK1.5), CD3 (145-2C11), CD28 (37.51), CD11c (HL3), B220 (RA3-6B2), gammac (4G3), IL-7Ralpha (SB199), Thy1.2 (30-H12), CD44 (IM7), CD62L (MEL-14), CCR5 (C34-3448), CXCR5 (2G8), and IL-17 (TC11-18H10; for IL-17A) were purchased from BD. Antibodies to CD30L (RM153), OX40L (RM134L), and CCR7 (4B12) were purchased from eBioscience. Anti-CCR6 antibody (clone 140706) was obtained from R&D Systems. Both anti-CXCR3 and -CCR4 antibodies were purchased from Abcam. alpha-GalCer was obtained from AXXORA, LLC.
###end p 37
###begin title 38
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 38
###begin p 39
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 74 77 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 127 132 123 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fl/fl</sup>
###xml 122 132 118 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat3<sup>fl/fl</sup></italic>
###xml 208 216 204 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMTV-Cre</italic>
###xml 234 239 230 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fl/fl</sup>
###xml 229 249 225 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat3<sup>fl/fl</sup>; MMTV-Cre</italic>
###xml 402 404 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 198 202 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 208 212 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 241 245 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
C57BL/6J WT mice (The Jackson Laboratory), Rag2-/- mice, and Rag2-/-gammac-/- mice (Taconic) were purchased as indicated. Stat3fl/fl mice were bred with mice expressing Cre under the control of the MMTV-LTR (MMTV-Cre) to produce Stat3fl/fl; MMTV-Cre mice (provided by L. Hennighhausen [National Institute of Diabetes and Digestive and Kidney Diseases] and D. Levy [New York University, New York, NY]) (30). All animal experiments were performed according to the National Institutes of Health (NIH) guidelines for laboratory animals and were approved by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Animal Care and Use Committee.
###end p 39
###begin title 40
Isolation of cells and cell culture.
###end title 40
###begin p 41
###xml 158 159 158 159 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Single-cell suspensions were prepared from spleens of healthy 8-10-wk-old mice. All cell cultures were performed in RPMI 1640 supplemented with 10% FBS, 2 mM l-glutamine, 5 mM Hepes, 100 U/ml Pen-Strep, and 2.5 muM 2-ME at 37degreesC for 4, 24, or 48 h. Cells stained with the appropriate antibodies were isolated by flow cytometric cell sorting using a Mo-Flo cell sorter (Dako). Whole splenocytes or isolated cells were cultured in the presence of 20 ng/ml IL-23, 20 ng/ml IL-4, 10 ng/ml IL-6, 20 ng/ml IL-7, 20 ng/ml IL-15, 20 ng/ml IL-2, 20 ng/ml IL-12, 100 ng/ml IL-21, or 5 ng/ml TGFbeta-1.
###end p 41
###begin title 42
Flow cytometric analysis and intracellular cytokine staining.
###end title 42
###begin p 43
###xml 568 571 567 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 805 807 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
Cells were stimulated for 2 h with 50 ng/ml PMA and 1 mug/ml Iono, followed by incubation with BFA (GolgiPlug; BD) for an additional 2 h. Cells were fixed in 4% formyl saline and permeabilized with 0.1% saponin permeabilization buffer after surface staining. PE-conjugated anti-IL-17 antibody was used to detect intracellular cytokine levels (BD). Stained cells with the appropriate antibodies were analyzed on a flow cytometer (FACSCalibur; BD). Events were collected and analyzed with FlowJo software (Tree Star, Inc.). To evaluate production of IL-17A in vivo, Rag2-/- mice were injected i.p. with 5 or 12.5 mg zymosan (Sigma-Aldrich). Control animals received PBS. To assess in vivo intracellular cytokine levels, 0.25 mg BFA (Sigma-Aldrich) was simultaneously injected i.v., as previously described (21).
###end p 43
###begin title 44
RNA isolation and measurement of cytokines.
###end title 44
###begin p 45
###xml 32 35 32 35 <sc xmlns:xlink="http://www.w3.org/1999/xlink">zol</sc>
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 86 87 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 118 119 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 128 132 128 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 136 139 136 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 248 249 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 252 253 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 258 259 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 263 264 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 396 401 <span type="species:ncbi:10090">mouse</span>
Total RNA was isolated using TRIzol reagent (Invitrogen) from freshly isolated CD4+CD3+CD62L-CD44+ memory T cells; CD4+CD3+CD62LhighCD44low naive T cells; CD19+ B cells, Th17 cells polarized with IL-6, TGFbeta-1, and anti-CD3/-CD28 for 3 d; and CD4+CD3-CD11c-B220- LTi-like cells. cDNA was synthesized with the TaqMan Reverse Transcription kit (Applied Biosystems). TaqMan primers and probes for mouse IL-17A, IL-17F, IL-22, IL-23R, IL-12Rbeta1, IL-12Rbeta2, RORc (for RORgammat), IL-17RA, IL-6Ralpha, CCR6, AHR, GATA3, and 18SrRNA (as endogenous control) were purchased from Applied Biosystems. Samples were analyzed by using a sequence detection system (ABI PRISM 7700; Applied Biosystems).
###end p 45
###begin p 46
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
###xml 140 145 <span type="species:ncbi:10090">mouse</span>
The amounts of cytokines in the culture supernatant were measured using mouse IL-17 Quantikine assay kits (for IL-17A; R&D Systems) and the mouse IL-22 ELISA construction kit (Antigenix America Inc.) according to the manufacturers' instructions. IL-23-mediated cell stimulations were performed at cell concentrations of 4 x 106 cells/ml. Samples were measured in duplicate against the standard curve of the assay.
###end p 46
###begin title 47
Data analysis.
###end title 47
###begin p 48
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Statistical significance was determined by the Student's t test. P < 0.05 was considered to indicate a significant difference.
###end p 48
###begin title 49
Online supplemental material.
###end title 49
###begin p 50
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 191 192 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 269 270 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 273 274 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 290 293 282 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
Fig. S1 shows IL-17A production by WT or Rag2-/- splenocytes in the presence of IL-23 with gammac-dependent cytokines, anti-CD3/-CD28, or alpha-GalCer. Fig. S2 shows that IL-17A-producing CD3- cells do not express myeloid markers. Fig. S3 shows three populations in CD4+CD3- cells from Rag2-/- spleens. Fig. S4 shows that LTi-negative subsets produce minimal IL-17A. Fig. S5 shows IL-17A production by LTi-like cells in the gut. Fig. S6 shows the surface expression of various markers on LTi-like cells. Fig. S7 shows mRNA expression of various factors in LTi-like cells after IL-23 stimulation with IL-7. Fig. S8 shows IL-22 and IL-17A production by isolated NK cells. Online supplemental material is available at .
###end p 50
###begin title 51
Supplementary Material
###end title 51
###begin title 52
[Supplemental Material Index]
###end title 52
###begin p 53
###xml 254 259 254 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fl/fl</sup>
###xml 249 269 249 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stat3<sup>fl/fl</sup>; MMTV-Cre</italic>
###xml 261 265 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
We thank J. Simone and the flow cytometry core, and the animal facility of the NIAMS for excellent advice and technical service. We thank Drs. H. Young and D. McVicar for helpful discussions. We thank Drs. L. Hennighhausen and D. Levy for providing Stat3fl/fl; MMTV-Cre mice.
###end p 53
###begin p 54
This research was supported by the Intramural Research Program, NIAMS, NIH.
###end p 54
###begin p 55
The authors have no conflicting financial interests.
###end p 55

